Company intelligence / Profile preview

OptiMedica

Sunnyvale, California, United States

Ownership: Private
Development stage: Other

Overview

OptiMedica developed the Catalys Precision Laser System, a next-generation laser cataract surgery platform, which has been FDA-cleared and CE-marked for performing every step of laser cataract surgery. The system integrates a femtosecond laser, 3D Optical Coherence Tomography imaging, and pattern scanning technology for precise, reproducible, and efficient cataract removal. The PASCAL retinal photocoagulator (later acquired by Topcon) and Catalys system were both commercialized, with Catalys widely adopted in leading ophthalmic practices globally[2].

Therapeutic areas: Ophthalmology
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on OptiMedica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OptiMedica.

Explore the full profile